TORONTO–(BUSINESS WIRE)–NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), owner and operator of a network of clinics that deliver category-leading treatment for chronic pain, as well as spinal injuries, sports-related injuries, and concussions, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 25, 2021.
The results of the director elections were as follows:
Name
Votes in Favour
% Votes in Favour
Votes Withheld
% Votes Withheld
Dianne Carmichael
22,614,341
98.97%
235,250
1.03%
Jolyon Burton
22,812,591
99.84%
37,000
0.16%
Daniel Chicoine
22,431,591
98.17%
418,000
1.83%
Sasha Cucuz
22,427,591
98.15%
422,000
1.85%
Dan Legault
22,438,591
98.20%
411,000
1.80%
Grishanth Ram
22,532,791
98.61%
316,800
1.39%
Joseph Walewicz
22,433,591
98.18%
416,000
1.82%
The shareholders of the Company also voted: (i) to set the number of directors of the Company at seven directors for the ensuing year; (ii) to reappoint Ernst & Young LLP, Chartered Professional Accounts, Licensed Public Accountants, as auditors of the Company for the ensuing year; and (iii) to approve, ratify and confirm the Company’s amended stock option plan in the form attached as Schedule “A” to the management information circular dated May 14, 2021 prepared in connection with the Meeting.
About NeuPath
NeuPath is a vertically integrated health care provider utilizing research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by chronic pain, spinal injuries, sport-related injuries, and concussions. With equity ownership in fifteen clinics in Ontario and Alberta, NeuPath is building out a large-scale network to better serve patients across Canada and the United States. NeuPath is focused on transforming the hope of a better life into the reality of a life more fully lived.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS THE RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.